NAT10 and colorectal carcinoma: Although NAT10 knockdown inactivated the PI3K-AKT pathway and inhibited CRC progression to some extent, Remodelin treatment alone induced only reversible growth arrest in CRC cells and demonstrated limited therapeutic efficacy.